STUDY REVEALS SOCIOECONOMIC BARRIERS TO CHILDREN’S HEALTHCARE ACCESS. NSW, WA and SA commence reforms allowing GPs to diagnosis and treat ADHD
With
Dr Anita Muñoz, General Practitioner &
Royal Australian College of GPs (RACGP) Victoria Chair
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | August 2025
Research published in the Australian Journal of General Practice (AJGP) has revealed mental health and developmental–behavioural issues such as ADHD are the most common paediatric referrals in metropolitan general practices.
But the research also revealed children at higher risk are less likely to get the care they may need.
The study of 49,932 consultations at 22 GP clinics in Victoria and New South Wales found private billing specialist GPs were around 1.7 times more likely to refer than bulk billing GPs in the sample – and most referrals were to private billing paediatric specialists.
Corresponding author, consultant paediatrician, and University of Melbourne Professor Harriet Hiscock said the study showed a clear difference in children’s access to appropriate care depending on their socioeconomic status.
She said the study showed the need for greater investment in primary care and public paediatric mental health services, as well as for integrated care between GPs and paediatricians.
“Children from lower socioeconomic areas are more likely to have mental health and developmental–behavioural problems than those from wealthier areas,” Professor Hiscock said.
“However, these children were more likely to attend bulk billing practices and received fewer referrals for specialist care.
“We need more investment in public specialist paediatric services and paediatric mental health services.
“We also need more investment in paediatric primary care, including properly funding longer GP-patient consults, funding co-consults between GPs and paediatric specialists, and empowering GPs to diagnose and treat developmental concerns such as ADHD, especially in lower socioeconomic areas.”
The governments of New South Wales, Western Australia and South Australia, have announced they will allow GPs to work to their full scope of practice to diagnose and treat ADHD. Children in Queensland have been able to access ADHD diagnosis and support for eight years.
GPs in Victoria, Tasmania and the Australian Capital Territory have also called for GPs to be able to diagnose ADHD to improve access to treatment. In Victoria, a shared care ADHD pilot is underway with GPs and paediatricians.
Australian Health Journal spoke with Royal Australian College of GPs (RACGP) Victoria Chair Dr Anita Muñoz about the study and the reform underway.
Source: Adapted from RACGP Media Release
-
Trends report identifies prototyping targets for breakthroughs in digital and hybrid futures
Vishaal Kishore, a Professor of Innovation and Public Policy at RMIT in Melbourne, serves as the Executive Chair of the RMIT-Cisco Health Transformation Lab and RMIT’s Director of Impact. Led by the RMIT-Cisco Health Transformation Lab, the National Industry Innovation Network (NIIN) Health Alliance combines the best minds, technologists, industry capabilities and academic resources to solve pressing industry and social challenges through technology-driven innovation. The NIIN aims to pool insights and expertise to address national health challenges, marking its first vertical focus on health.
-
Job-ready clinical trial interns
The Victorian Comprehensive Cancer Centre Alliance, or VCCC Alliance for short, is a Victorian partnership of 10 research, academic and clinical institutions looking at improving cancer outcomes for patients.
The VCCC Alliance SKILLED clinical trial internships program is a pathway for scientists to build role-specific clinical trial knowledge, experience and in a clinical trials unit through theoretical and on-the-job training. The internship program is a 40 week intensive program to get science student interns job ready for clinical trial assistant and study coordinator internship roles.
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
